Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.

Twelves, C.J., 2006.

Clin Colorectal Cancer 6, 278–287.

Studie: X-ACT; Indikation: Kolorektalkarzinom; Jahr: 2006; Veranstaltung: -; Journal: Clinical Colorectal Cancer

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com